Next Article in Journal
Endothelial Cells Tissue-Specific Origins Affects Their Responsiveness to TGF-β2 during Endothelial-to-Mesenchymal Transition
Next Article in Special Issue
Intermittent Hypoxia Up-Regulates Gene Expressions of Peptide YY (PYY), Glucagon-like Peptide-1 (GLP-1), and Neurotensin (NTS) in Enteroendocrine Cells
Previous Article in Journal
A Potential Lock-Type Mechanism for Unconventional Secretion in Fungi
Previous Article in Special Issue
Obstructive Sleep Apnea Activates HIF-1 in a Hypoxia Dose-Dependent Manner in HCT116 Colorectal Carcinoma Cells
 
 
Review

Obstructive Sleep Apnea and Inflammation: Proof of Concept Based on Two Illustrative Cytokines

Child Health Research Institute, Department of Child Health, University of Missouri School of Medicine, Columbia, MO 65201, USA
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2019, 20(3), 459; https://doi.org/10.3390/ijms20030459
Received: 21 December 2018 / Revised: 12 January 2019 / Accepted: 15 January 2019 / Published: 22 January 2019
(This article belongs to the Special Issue Sleep Apnea and Intermittent Hypoxia)
Obstructive sleep apnea syndrome (OSAS) is a markedly prevalent condition across the lifespan, particularly in overweight and obese individuals, which has been associated with an independent risk for neurocognitive, behavioral, and mood problems as well as cardiovascular and metabolic morbidities, ultimately fostering increases in overall mortality rates. In adult patients, excessive daytime sleepiness (EDS) is the most frequent symptom leading to clinical referral for evaluation and treatment, but classic EDS features are less likely to be reported in children, particularly among those with normal body-mass index. The cumulative evidence collected over the last two decades supports a conceptual framework, whereby sleep-disordered breathing in general and more particularly OSAS should be viewed as low-grade chronic inflammatory diseases. Accordingly, it is assumed that a proportion of the morbid phenotypic signature in OSAS is causally explained by underlying inflammatory processes inducing end-organ dysfunction. Here, the published links between OSAS and systemic inflammation will be critically reviewed, with special focus on the pro-inflammatory cytokines tumor necrosis factor α (TNF-α) and interleukin 6 (IL-6), since these constitute classical prototypes of the large spectrum of inflammatory molecules that have been explored in OSAS patients. View Full-Text
Keywords: sleep apnea; inflammation; cytokines; excessive daytime sleepiness; sleep sleep apnea; inflammation; cytokines; excessive daytime sleepiness; sleep
Show Figures

Figure 1

MDPI and ACS Style

Kheirandish-Gozal, L.; Gozal, D. Obstructive Sleep Apnea and Inflammation: Proof of Concept Based on Two Illustrative Cytokines. Int. J. Mol. Sci. 2019, 20, 459. https://doi.org/10.3390/ijms20030459

AMA Style

Kheirandish-Gozal L, Gozal D. Obstructive Sleep Apnea and Inflammation: Proof of Concept Based on Two Illustrative Cytokines. International Journal of Molecular Sciences. 2019; 20(3):459. https://doi.org/10.3390/ijms20030459

Chicago/Turabian Style

Kheirandish-Gozal, Leila, and David Gozal. 2019. "Obstructive Sleep Apnea and Inflammation: Proof of Concept Based on Two Illustrative Cytokines" International Journal of Molecular Sciences 20, no. 3: 459. https://doi.org/10.3390/ijms20030459

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop